Metformin, a common, safe and inexpensive drug for type 2 diabetes, lowered the odds of emergency department visits, hospitalizations or death due to COVID-19 by over 40 percent, according to a new multi-site clinical trial.
Menu
Month: August 2022
A new Northwestern Medicine trial will test whether a telehealth-based intervention that addresses three behavioral risk factors at once can modify cancer patients’ lifestyles to improve their outcomes.
Bigger test panels are better for genetic testing in cardiomyopathy and heart arrhythmias, according to a recent Northwestern Medicine study.
An inflammatory signaling protein called interleukin-6 has been linked to the progression of acute myeloid leukemia, representing a potential target for future treatments of the disease.
An emerging therapy showed promise in patients with relapsed B-cell lymphoma who are not ideal candidates for stem cell transplants.
A new study has identified a molecular switch, through a protein called CDK9, that plays an early and critical role in the skin stem cell differentiation process.
Northwestern Medicine investigators have discovered novel mechanisms underlying transcription elongation, the process of synthesizing RNA from DNA.
First-year medical students donned their white coats for the first time at Founders’ Day, an annual event that celebrates incoming medical students and marks the official start of the academic year.
An immune system kinase promotes tumor inflammation and progression, according to a study published in Nature Communications.
Northwestern Medicine investigators have identified a new type of retinal ganglion cell, neurons that encode the visual environment and transmit information back to the brain.